NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding NexImmune, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 46 | 39 | −7 |
| Shares | 8.30M | 7.84M | −462.6K (−5.6%) |
| Value | $13.4M | $4.34M | −$9.02M (−67.5%) |
New holders (6)
Institutions that held NexImmune, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Man Group plc | 20,336 | $11.0K | 0.00% |
| Renaissance Technologies LLC | 12,700 | $7.00K | 0.00% |
| Davenport & Co LLC | 10,500 | $6.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 1,349 | $748 | 0.00% |
| Royal Bank of Canada | 48 | $0 | 0.00% |
| Advisor Group Holdings, Inc. | 150 | $0 | 0.00% |
Sold out (13)
Institutions that held NexImmune, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ergoteles LLC | 86,200 | $139.0K |
| Citadel Advisors LLC | 42,321 | $68.0K |
| Goldman Sachs Group Inc | 29,084 | $47.0K |
| Bailard, Inc. | 20,285 | $33.0K |
| Baker Bros. Advisors LP | 20,000 | $32.0K |
| Truist Financial Corp | 10,000 | $18.0K |
| CIBC Private Wealth Group, LLC | 10,253 | $17.0K |
| Barclays PLC | 1,173 | $2.00K |
| Legal & General Group Plc | 1,414 | $2.00K |
| Citigroup Inc | 669 | $1.00K |
| New York State Common Retirement Fund | 159 | $0 |
| Credit Suisse AG | 9 | $0 |
| Ellevest, Inc. | 5 | $0 |